Lan Cao
- Biomaterials top 5%
- Immunology top 10%
- Molecular Medicine top 5%
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 3
-
- Phytochemistry and Biological Activities 5
-
- Acute Myeloid Leukemia Research 4
-
- Natural product bioactivities and synthesis 4
- RNA modifications and cancer 3
- Angiogenesis and VEGF in Cancer 3
-
- Sesquiterpenes and Asteraceae Studies 4
-
- Cancer Immunotherapy and Biomarkers 3
Lan Cao
61 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 122
- Biomaterials 257
- Immunology 335
- Molecular Medicine 76
- Reproductive Medicine 117
- Critical Care and Intensive Care Medicine 56
Countries citing papers authored by Lan Cao
This map shows the geographic impact of Lan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Cao more than expected).
Fields of papers citing papers by Lan Cao
This network shows the impact of papers produced by Lan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Cao. The network helps show where Lan Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lan Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 23 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 19 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 18 | |
| 14 | 2020 | 48 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 1 | |
| 17 | 2017 | 30 | |
| 18 | 2015 | 7 | |
| 19 | 2010 | 95 | |
| 20 | 2005 | 39 |
About Lan Cao
Lan Cao is a scholar working on Cancer Research, Critical Care and Intensive Care Medicine and Emergency Medicine, having authored 67 papers that have together received 1.6k indexed citations. Recurring topics across this work include Phytochemistry and Biological Activities (5 papers), Acute Myeloid Leukemia Research (4 papers), Natural product bioactivities and synthesis (4 papers), Sesquiterpenes and Asteraceae Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Ovarian cancer diagnosis and treatment (3 papers), RNA modifications and cancer (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Biomaterials (257 citations), Immunology (335 citations) and Molecular Medicine (76 citations). Lan Cao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include David Mooney, Nathaniel Huebsch, Glenn Dranoff, Omar A. Ali, Jaeyun Kim, Hyunjoon Kong, Eduardo A. Silva, Daniel Nguyen, Yu Zhang and Chaenyung Cha. Their work appears in journals such as Chemistry & Biodiversity, Biomaterials, Journal of Systematics and Evolution, Chinese Journal of Chemistry and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.